These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy. Mattson RH, Petroff O, Rothman D, Behar K. Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467 [Abstract] [Full Text] [Related]
5. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics. Mueller SG, Weber OM, Duc CO, Weber B, Meier D, Russ W, Boesiger P, Wieser HG. Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782 [Abstract] [Full Text] [Related]
6. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. White HS. Epilepsia; 1999 Jan; 40 Suppl 5():S2-10. PubMed ID: 10530688 [Abstract] [Full Text] [Related]
8. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Jambaqué I, Chiron C, Dumas C, Mumford J, Dulac O. Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043 [Abstract] [Full Text] [Related]
9. Vigabatrin for tuberous sclerosis complex. Curatolo P, Verdecchia M, Bombardieri R. Brain Dev; 2001 Nov; 23(7):649-53. PubMed ID: 11701271 [Abstract] [Full Text] [Related]
10. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Sills GJ, Butler E, Forrest G, Ratnaraj N, Patsalos PN, Brodie MJ. Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570 [Abstract] [Full Text] [Related]
11. Visual fields at school-age in children treated with vigabatrin in infancy. Gaily E, Jonsson H, Lappi M. Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279 [Abstract] [Full Text] [Related]
12. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms. Granström ML, Gaily E, Liukkonen E. Epilepsia; 1999 Jul; 40(7):950-7. PubMed ID: 10403219 [Abstract] [Full Text] [Related]
14. Current role of vigabatrin in infantile spasms. Parisi P, Bombardieri R, Curatolo P. Eur J Paediatr Neurol; 2007 Nov; 11(6):331-6. PubMed ID: 17625936 [Abstract] [Full Text] [Related]
15. Mechanism of action of vigabatrin: correcting misperceptions. Ben-Menachem E. Acta Neurol Scand Suppl; 2011 Nov; (192):5-15. PubMed ID: 22061176 [Abstract] [Full Text] [Related]
16. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Camposano SE, Major P, Halpern E, Thiele EA. Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386 [Abstract] [Full Text] [Related]
17. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine. Sills GJ. Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297 [Abstract] [Full Text] [Related]
18. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism. Spanaki MV, Siegel H, Kopylev L, Fazilat S, Dean A, Liow K, Ben-Menachem E, Gaillard WD, Theodore WH. Neurology; 1999 Oct 22; 53(7):1518-22. PubMed ID: 10534261 [Abstract] [Full Text] [Related]